Jon Sussman

1.5k total citations
30 papers, 752 citations indexed

About

Jon Sussman is a scholar working on Neurology, Neurology and Pharmacology. According to data from OpenAlex, Jon Sussman has authored 30 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 5 papers in Neurology and 3 papers in Pharmacology. Recurrent topics in Jon Sussman's work include Myasthenia Gravis and Thymoma (13 papers), Peripheral Neuropathies and Disorders (5 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Jon Sussman is often cited by papers focused on Myasthenia Gravis and Thymoma (13 papers), Peripheral Neuropathies and Disorders (5 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Jon Sussman collaborates with scholars based in United Kingdom, Australia and United States. Jon Sussman's co-authors include Neil Scolding, Christopher E. Shaw, G.A.B. Davies-Jones, Maria Elena Farrugia, Marguerite Hill, David Hilton‐Jones, Paul Maddison, Maria Isabel Leite, D. A. S. Compston and P. J. Rayner and has published in prestigious journals such as Neurology, Cochrane Database of Systematic Reviews and Annals of the New York Academy of Sciences.

In The Last Decade

Jon Sussman

29 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Sussman United Kingdom 14 382 120 112 96 84 30 752
Sophie Binks United Kingdom 11 565 1.5× 27 0.2× 103 0.9× 70 0.7× 60 0.7× 35 808
Mark B. Skeen United States 8 705 1.8× 69 0.6× 207 1.8× 240 2.5× 77 0.9× 21 1.1k
Shalom Haggiag Italy 17 260 0.7× 48 0.4× 93 0.8× 103 1.1× 77 0.9× 51 710
Stacey Clardy United States 18 819 2.1× 24 0.2× 173 1.5× 137 1.4× 82 1.0× 75 1.2k
R. Gold Germany 9 80 0.2× 57 0.5× 57 0.5× 68 0.7× 55 0.7× 22 353
Jan Debruyne Belgium 12 165 0.4× 58 0.5× 146 1.3× 115 1.2× 180 2.1× 14 690
Adriana Roca‐Fernández United Kingdom 14 605 1.6× 38 0.3× 89 0.8× 67 0.7× 60 0.7× 20 988
Paola Naldi Italy 17 232 0.6× 22 0.2× 72 0.6× 75 0.8× 182 2.2× 41 726
Leonardo Vedolin Brazil 20 165 0.4× 48 0.4× 242 2.2× 236 2.5× 88 1.0× 58 1.1k
Barbara Willekens Belgium 13 140 0.4× 23 0.2× 74 0.7× 46 0.5× 54 0.6× 49 557

Countries citing papers authored by Jon Sussman

Since Specialization
Citations

This map shows the geographic impact of Jon Sussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Sussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Sussman more than expected).

Fields of papers citing papers by Jon Sussman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Sussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Sussman. The network helps show where Jon Sussman may publish in the future.

Co-authorship network of co-authors of Jon Sussman

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Sussman. A scholar is included among the top collaborators of Jon Sussman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Sussman. Jon Sussman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacob, Saiju, Maria Elena Farrugia, Channa Hewamadduma, et al.. (2025). Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update). Practical Neurology. 25(5). 422–437. 1 indexed citations
2.
Dodd, Katherine, Fiona J. Clay, J. Handley, et al.. (2025). Rituximab for myasthenia gravis. Cochrane Database of Systematic Reviews. 2025(7). CD014574–CD014574. 1 indexed citations
3.
Dodd, Katherine, James Holt, Saiju Jacob, et al.. (2024). Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis. Neuromuscular Disorders. 38. 51–57. 2 indexed citations
4.
Sussman, Jon, et al.. (2023). A successful antenatal outcome in a patient with refractory Takayasu’s arteritis treated with tocilizumab throughout pregnancy—a case report. Oxford Medical Case Reports. 2023(5). omad046–omad046. 1 indexed citations
5.
Dodd, Katherine, Fiona J. Clay, Ryan Keh, et al.. (2023). Rituximab for myasthenia gravis. Cochrane Database of Systematic Reviews. 2023(4). 3 indexed citations
6.
Sussman, Jon, Daniel S. Ubl, Kristopher P. Croome, et al.. (2021). Variation in opioid prescribing patterns after abdominal transplant surgery. Clinical Transplantation. 35(10). e14439–e14439. 6 indexed citations
7.
Kling, Juliana M., et al.. (2020). Transgender Health Care Curriculum Development: A Dual-Site Medical School Campus Pilot. Health Equity. 4(1). 102–113. 21 indexed citations
8.
Seldin, Michael F., Omar K. Alkhairy, Annette T. Lee, et al.. (2015). Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations. Molecular Medicine. 21(1). 769–781. 48 indexed citations
9.
Sussman, Jon. (2015). Musician’s dystonia. Practical Neurology. 15(4). 317–322. 14 indexed citations
10.
Sussman, Jon, et al.. (2012). Further developments with antisense treatment for myasthenia gravis. Annals of the New York Academy of Sciences. 1275(1). 13–16. 18 indexed citations
11.
Sussman, Jon, et al.. (2008). Antisense Treatment for Myasthenia Gravis. Annals of the New York Academy of Sciences. 1132(1). 283–290. 34 indexed citations
12.
Sussman, Jon, et al.. (2004). Focal dystonia after removal of a parietal meningioma. Movement Disorders. 19(6). 714–716. 6 indexed citations
13.
Harkness, K. A., Jon Sussman, G.A.B. Davies-Jones, John Greenwood, & M. Nicola Woodroofe. (2003). Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. Journal of Neuroimmunology. 142(1-2). 1–9. 69 indexed citations
14.
Sussman, Jon. (2000). Immunological and Inflammatory Disorders Of the Central Nervous System. Journal of Neurology Neurosurgery & Psychiatry. 68(1). 123a–123. 5 indexed citations
15.
Sussman, Jon, et al.. (1998). Olanzapine in the treatment of hallucinosis in idiopathic parkinson's disease: a cautionary note. Journal of Neurology Neurosurgery & Psychiatry. 65(5). 774–777. 63 indexed citations
16.
Harkness, K. A., Alison K. Cross, M. Nicola Woodroofe, Jon Sussman, & G.A.B. Davies-Jones. (1998). Chemokine expression in vitro: A comparative study of microglia and CNS vascular Endothelium. Journal of Neuroimmunology. 90(1). 22–22. 1 indexed citations
17.
Compston, Alastair, John Zajicek, Jon Sussman, et al.. (1997). Review: Glial lineages and myelination in the central nervous system. Journal of Anatomy. 190(2). 161–200. 85 indexed citations
18.
Scolding, Neil, P. J. Rayner, Jon Sussman, Christopher E. Shaw, & D. A. S. Compston. (1995). A proliferative adult human oligodendrocyte progenitor. Neuroreport. 6(3). 441–445. 87 indexed citations
19.
Sussman, Jon & D. A. S. Compston. (1994). Subacute sclerosing panencephalitis in wales. QJM. 87(1). 23–34. 4 indexed citations
20.
Jd, Woodruff, et al.. (1989). Vulvitis circumscripta plasmocellularis. A report of four cases.. PubMed. 34(5). 369–72. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026